1
|
Mackie K: Cannabinoid receptors: Where
they are and what they do. J Neuroendocrinol. 20(Suppl 1): S10–S14.
2008. View Article : Google Scholar
|
2
|
Guillot A, Hamdaoui N, Bizy A, Zoltani K,
Souktani R, Zafrani ES, Mallat A, Lotersztajn S and Lafdil F:
Cannabinoid receptor 2 counteracts interleukin-17-induced immune
and fibrogenic responses in mouse liver. Hepatology. 59:296–306.
2014. View Article : Google Scholar
|
3
|
Balistreri E, Garcia-Gonzalez E, Selvi E,
Akhmetshina A, Palumbo K, Lorenzini S, Maggio R, Lucattelli M,
Galeazzi M and Distler JW: The cannabinoid WIN55, 212-2 abrogates
dermal fibrosis in scleroderma bleomycin model. Ann Rheum Dis.
70:695–699. 2011. View Article : Google Scholar
|
4
|
Servettaz A, Kavian N, Nicco C, Deveaux V,
Chéreau C, Wang A, Zimmer A, Lotersztajn S, Weill B and Batteux F:
Targeting the cannabinoid pathway limits the development of
fibrosis and autoimmunity in a mouse model of systemic sclerosis.
Am J Pathol. 177:187–196. 2010. View Article : Google Scholar : PubMed/NCBI
|
5
|
Zheng JL, Yu TS, Li XN, Fan YY, Ma WX, Du
Y, Zhao R and Guan DW: Cannabinoid receptor type 2 is
time-dependently expressed during skin wound healing in mice. Int J
Legal Med. 126:807–814. 2012. View Article : Google Scholar : PubMed/NCBI
|
6
|
Artlett CM: Inflammasomes in wound healing
and fibrosis. J Pathol. 229:157–167. 2013. View Article : Google Scholar
|
7
|
Singer AJ and Clark RA: Cutaneous wound
healing. N Engl J Med. 341:738–746. 1999. View Article : Google Scholar : PubMed/NCBI
|
8
|
Finnson KW, Arany PR and Philip A:
Transforming growth factor beta signaling in cutaneous wound
healing: Lessons learned from animal studies. Adv Wound Care (New
Rochelle). 2:225–237. 2013. View Article : Google Scholar
|
9
|
Branton MH and Kopp JB: TGF-beta and
fibrosis. Microbes Infect. 1:1349–1365. 1999. View Article : Google Scholar : PubMed/NCBI
|
10
|
Zarruk JG, Fernández-López D,
García-Yébenes I, García-G utiérrez MS, Vivancos J, Nombela F,
Torres M, Burguete MC, Manzanares J, Lizasoain I and Moro MA:
Cannabinoid type 2 receptor activation downregulates stroke-induced
classic and alternative brain macrophage/microglial activation
concomitant to neuroprotection. Stroke. 43:1211–219. 2012.
View Article : Google Scholar
|
11
|
US Office of Science and Technology
Policy: Laboratory animal welfare: U.S. government principles for
the utilization and care of vertebrate animals used in testing,
research and training; notice. Fed Regist. 50:20864–20865.
1995.
|
12
|
Wang X, Ge J, Tredget EE and Wu Y: The
mouse excisional wound splinting model, including applications for
stem cell transplantation. Nat Protoc. 8:302–309. 2013. View Article : Google Scholar : PubMed/NCBI
|
13
|
Galiano RD, Michaels J V, Dobryansky M,
Levine JP and Gurtner GC: Quantitative and reproducible murine
model of excisional wound healing. Wound Repair Regen. 12:485–492.
2004. View Article : Google Scholar : PubMed/NCBI
|
14
|
Ansell DM, Campbell L, Thomason HA, Brass
A and Hardman MJ: A statistical analysis of murine incisional and
excisional acute wound models. Wound Repair Regen. 22:281–287.
2014. View Article : Google Scholar : PubMed/NCBI
|
15
|
Guabiraba R1, Russo RC, Coelho AM,
Ferreira MA, Lopes GA, Gomes AK, Andrade SP, Barcelos LS and
Teixeira MM: Blockade of cannabinoid receptors reduces
inflammation, leukocyte accumulation and neovascularization in a
model of sponge-induced inflammatory angiogenesis. Inflamm Res.
62:811–821. 2013. View Article : Google Scholar : PubMed/NCBI
|
16
|
Del Fabbro L, Borges Filho C, Cattelan
Souza L, Savegnago L, Alves D, Henrique Schneider P, de Salles HD
and Jesse CR: Effects of Se-phenyl thiazolidine-4-carboselenoate on
mechanical and thermal hyperalgesia in brachial plexus avulsion in
mice: Mediation by cannabinoid CB1 and CB2 receptors. Brain Res.
1475:31–36. 2012. View Article : Google Scholar : PubMed/NCBI
|
17
|
Gorantla S, Makarov E, Roy D, Finke-Dwyer
J, Murrin LC, Gendelman HE and Poluektova L: Immunoregulation of a
CB2 receptor agonist in a murine model of neuroAIDS. J Neuroimmune
Pharmacol. 5:456–468. 2010. View Article : Google Scholar : PubMed/NCBI
|
18
|
Bíró T, Tóth BI, Haskó G, Paus R and
Pacher P: The endocannabinoid system of the skin in health and
disease: Novel perspectives and therapeutic opportunities. Trends
Pharmacol Sci. 30:411–420. 2009. View Article : Google Scholar : PubMed/NCBI
|
19
|
Mahmoud MF, Swefy SE, Hasan RA and Ibrahim
A: Role of cannabinoid receptors in hepatic fibrosis and apoptosis
associated with bile duct ligation in rats. Eur J Pharmacol.
742:118–124. 2014. View Article : Google Scholar : PubMed/NCBI
|
20
|
Brunner G and Blakytny R: Extracellular
regulation of TGF-beta activity in wound repair: Growth factor
latency as a sensor mechanism for injury. Thromb Haemost.
92:253–261. 2004.PubMed/NCBI
|
21
|
Lee TY, Lee KC and Chang HH: Modulation of
the cannabinoid receptors by andrographolide attenuates hepatic
apoptosis following bile duct ligation in rats with fibrosis.
Apoptosis. 15:904–914. 2010. View Article : Google Scholar : PubMed/NCBI
|
22
|
Defer N, Wan J, Souktani R, Escoubet B,
Perier M, Caramelle P, Manin S, Deveaux V, Bourin MC, Zimmer A, et
al: The cannabinoid receptor type 2 promotes cardiac myocyte and
fibroblast survival and protects against
ischemia/reperfusion-induced cardiomyopathy. FASEB J. 23:2120–2130.
2009. View Article : Google Scholar : PubMed/NCBI
|
23
|
Fujii M, Sherchan P, Krafft PR, Rolland
WB, Soejima Y and Zhang JH: Cannabinoid type 2 receptor stimulation
attenuates brain edema by reducing cerebral leukocyte infiltration
following subarachnoid hemorrhage in rats. J Neurol Sci.
342:101–106. 2014. View Article : Google Scholar : PubMed/NCBI
|
24
|
Yu T, Wang X, Zhao R, Zheng J, Li L, Ma W,
Zhang S and Guan D: Beneficial effects of cannabinoid receptor type
2 (CB2R) in injured skeletal muscle post-contusion. Histol
Histopathol. 30:737–749. 2015.PubMed/NCBI
|
25
|
Finnson KW, McLean S, Di Guglielmo GM and
Philip A: Dynamics of transforming growth factor beta signaling in
wound healing and scarring. Adv Wound Care (New Rochelle).
2:195–214. 2013. View Article : Google Scholar
|
26
|
Yan X and Chen YG: Smad7: Not only a
regulator, but also a cross-talk mediator of TGF-β signalling.
Biochem J. 434:1–10. 2011. View Article : Google Scholar : PubMed/NCBI
|